J Korean Neurosurg Soc.  2002 Aug;32(2):118-124.

Surgical Treatment of Spinal Plasma Cell Tumors

Affiliations
  • 1Department of Neurosurgery, Yonsei University, College of Medicine, Seoul, Korea.

Abstract


OBJECTIVE
The purpose of this study is to review the cases of spinal plasma cell tumors treated in our department with regard to presenting symptoms and signs, diagnostic investigations, extent of surgical interventions, complications, survival time and influence on the quality of life.
METHODS
In a retrospective study, twelve spinal plasma cell tumor patients who underwent surgery were evaluated between Oct. 1991 and Dec. 2000. Clinical staging system was evaluated by Durie-Salmon Staging System.
RESULTS
There were multiple myeloma in nine and solitary plasmacytoma in three patients, six men and six women and aged 38 to 69 years(mean 56.8 years). The locations of the lesions were two cervical, two cervico-thoracic, three thoracic, one thoraco-lumbar, three lumbar and one sacral. The most common initial presenting symptom and sign were local pain and motor weakness. Radiographs showed pathologic compression fracture in six and the MRI finding were cortical infolding, focal to diffuse patterns of low-signal on T1WI, high signal intensity on T2WI, and variable of enhancement on Gadolinium enhanced T1W1. Sixteen operations were performed. and the adjuvant theraphy included radiotheraphy, chemotheraphy(combined oral melphalan and predinisone), and autologous PBST(peripheral blood stem cell transplantation). The follow-up period was three to sixty months(mean 27.0 months). The mean Karnofsky scale score was changed from 54.5 to 73.3 after follow up. One patient died of pulmonary metastasis and sepsis.
CONCLUSION
Our experience suggests that treatment of spinal plasma cell tumor may be rewarding.

Keyword

Spinal plasma cell tumor; Surgical intervention; PMMA(polymethylmethacrylate)

MeSH Terms

Female
Follow-Up Studies
Fractures, Compression
Gadolinium
Humans
Karnofsky Performance Status
Magnetic Resonance Imaging
Male
Melphalan
Multiple Myeloma
Neoplasm Metastasis
Plasma Cells*
Plasma*
Plasmacytoma*
Quality of Life
Retrospective Studies
Reward
Sepsis
Stem Cells
Gadolinium
Melphalan
Full Text Links
  • JKNS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr